To determine the effect of increased glycogen stores on hepatic carbohydrate metabolism, 15 nondiabetic volunteers were studied before and after 4 d of progressive overfeeding. Glucose production and gluconeogenesis were assessed with [2-3H] glucose and [6-14C] glucose (Study I, n = 6) or [3-3H] glucose and [U-14C]-alanine (Study II, n = 9) and substrate oxidation was determined by indirect calorimetry. Overfeeding was associated with significant (P < 0.01) increases in plasma glucose (4.97 +/-0.10 to 5.09 +/-0.11 mmol/liter), insulin (18.8 +/-1.5 to 46.6 +/-10.0 pmol/liter) and carbohydrate oxidation (4.7 +/-1.4 to 18.0 +/-1.5 mumol.kg-1.min-1) and a decrease in lipid oxidation (1.2 +/-0.2 to 0.3 +/-0.1 mumol.kg-1.min-1). Hepatic glucose output (HGO) increased in Study I (10.2 +/-0.5 to 13.1 +/-0.9 mumol.kg-1.min-1, P < 0.01) and Study II (11.17 +/-0.67 to 13.33 +/-0.83 mumol.kg-1.min-1, P < 0.01), and gluconeogenesis decreased (57.6 +/-6.4 to 33.4 +/-4.9 mumol/min, P < 0.01), indicating an increase in glycogenolysis. The increase in glycogenolysis was only partly compensated by an increase in glucose cycle activity (2.2 +/-0.2 to 3.4 +/-0.4 mumol.kg-1.min-1, P < 0.01) and the fall in gluconeogenesis, thus resulting in increased HGO. The suppression of gluconeogenesis despite increased lactate and alanine (glycerol was decreased) was associated with decreased free fatty […] 
Introduction
Two observations suggest that hepatic glycogen stores may play a role in the increased hepatic glucose output (HGO)' observed in patients with non-insulin-dependent diabetes mellitus (NIDDM). First, we (1) and others (2, 3) have shown that liver glycogen stores, presumably formed by the indirect (gluconeogenic) pathway, are actually well preserved in the diabetic state. Second, the beneficial effect of caloric restriction on HGO in patients with NIDDM occurs despite continued gluconeogenesis (4), suggesting a reduction in glycogenolysis as the cause of the improvement. Although rates of gluconeogenesis are increased in patients with NIDDM (5, 6) , this alone should not be sufficient to increase HGO since an increase in gluconeogenesis is associated with a compensatory fall in glycogenolysis in nondiabetic subjects (7) (8) (9) . Therefore, we have proposed that continued glycogen release as well as increased gluconeogenesis is responsible for the increase in HGO in diabetic patients.
To examine the effect of increased glycogen stores on glucokinetics and hepatic metabolism, we have performed a series of overfeeding studies projected to greatly enlarge hepatic glycogen stores in normal volunteers (10) . Under these conditions, we have demonstrated an increase in HGO and glucose cycling and suppression of gluconeogenesis. These studies indicating a loss of normal intrahepatic mechanisms which reciprocally regulate gluconeogenesis and glycogenolysis when glycogen stores are greatly increased are consistent with an important contributory role of preserved glycogen stores in NIDDM where the autoregulatory mechanisms are already impaired. (Table I) were enrolled for the metabolic studies. Body composition was determined by skinfold measurements ( 11) and bioimpedance performed after an overnight fast ( 12) . Six of the subjects participated in studies examining the effect of overfeeding on glucose cycle activity (study I) and the remaining nine subjects were enrolled in studies to determine the effect of overfeeding on FFA-stimulated gluconeogenesis (study II). All of the subjects were in good health with stable body weights at the time of the studies. None had a family history of diabetes mellitus. Women were studied during the early follicular phase of their menstrual cycles and none of the women were taking exogenous estrogens or progestins. The studies were approved by the Committee for the Conduct of Human Research at the Medical College of Virginia/Virginia Commonwealth University and informed consent was obtained from each subject prior to enrollment in the protocols.
Methods 15 normal volunteers

Study diets
Before admission to the General Clinical Research Center, each subject was interviewed by a nutritionist to determine usual caloric intake and composition. The diet was then individually designed to increase caloric intake by -4.0 mJ (1,000 kcal) daily as previously described (10, 13) . Mean baseline intake was 7.5+0.5 MJ and increased to 23.5+0.6 MJ on the last day of the study. Composition of the diet was 67% carbohydrate, 22% fat and 11% protein.
Study design
All subjects were admitted to the Clinical Research Center at the Medical College of Virginia for the five-day studies. Metabolic assessments were performed supine after an overnight (10 h) fast on day 1 (before overfeeding) and day 5 (after overfeeding). Subjects received only water or ice chips during the two metabolic assessment periods. Vigorous 
Isotopic analyses
Aliquots of plasma for the determination of glucose specific activity were deproteinized with Ba(OH)2 and ZnSO4 (21) and the supernatant was chromatographed over sequential anion and cation exchange resins as previously described (8) . For studies in which [6-4C]glucose was infused, the neutral fraction was air-dried and was resuspended in 133 mM phosphate buffer (pH 7.4) and was divided into two equal fractions. 
Results
Effect of overfeeding on intermediary metabolism. The effects of overfeeding on basal energy expenditure, substrate metabolism, and body weight for all subjects (n = 15) are shown in Table III . Mean non-protein respiratory quotient (NPRQ) increased from 0.78±0.02 to 0.94±0.01 in the 15 study subjects (P < 0.001). In four of the subjects, the NPRQ exceeded 1.00 after overfeeding, indicating net lipogenesis. Overfeeding also (Fig. 1) . Glucose cycling (the difference between Ra23H and Ra'4c) also increased significantly during the 5-d overfeeding study from 2.2+0.2 to 3.4+0.4 umol kg-' min-' (P < 0.01, Fig. 1 (Fig. 3) . However, clear differences in the gluconeogenic response to lipid infusion were observed on the two study days. Alanine gluconeogenesis increased significantly from baseline during lipid administration on day 1 (P < 0.05), but did not increase during lipid administration on day 5 (Fig. 3 ).
Discussion
We have demonstrated an increase in hepatic glucose production after overfeeding in non-diabetic subjects. This increase 1500 -occurred despite an increase in plasma insulin. In the postabsorptive state, HGO is derived from both gluconeogenesis and glycogenolysis which are tightly linked to maintain HGO at a level to meet peripheral glucose demands (8) . Numerous studies examining the effect of stimulation (7, 8) (27) . In contrast, the present studies examined HGO under conditions which would be expected to increase liver glycogen stores (10) . Our data suggest that under these conditions, gluconeogenesis is suppressed and that glucose derived from glycogen is released in excess of metabolic needs, accounting for the increase in HGO.
In the present studies, HGO was measured by tracer techniques using infusions of either [2-3H] (28) , our data are consistent with an increase in net glucose production by the liver. It seems likely that liver glycogen stores were increased by overfeeding in our studies. Although liver glycogen stores were not measured in our subjects, Nilsson has shown increased liver glycogen stores in liver biopsies from nondiabetic subjects after ingestion of 300 gm/d carbohydrate for 1-5 d (32) . During the present studies, carbohydrate intake began at 300 gmld and increased to 900 gm/d by the fourth day of overfeeding. Using this protocol, whole body carbohydrate storage has been estimated to increase to 15 gm/kg total body weight (10). Assuming maximum muscle glycogen storage to be 2.4% (33) and muscle mass to be 40% of body weight, liver glycogen concentrations in our subjects may have exceeded 1000 Mmol/L, a value threefold greater than normal postabsorptive levels (32) . However, continued storage of liver glycogen may have been attenuated by an increase in glycogen release which occurs with increasing glycogen content (34, 35) . Since rates of gluconeogenesis decreased with overfeeding, increased glycogen release seems the likely source for the increase in HGO observed in our studies.
We have previously demonstrated an increase in glycogenolysis when gluconeogenesis was inhibited by ethanol administration in diabetic and nondiabetic individuals (4) which has been confirmed in animal studies (36) . The conditions associated with overfeeding would also be expected to suppress gluconeogenesis. In the postabsorptive state, the liver derives the majority of its energy from the oxidation of FFA which also promotes gluconeogenesis (Fig. 3) . After several days of overfeeding, hepatic FFA oxidation is replaced by carbohydrate oxidation, in part related to the expected reduction in FFA availability as well as insulin-mediated increases in fructose-2,6-bisphosphate (37) and malonyl-CoA which inhibits FFA oxidation (38) . The failure of Intralipid administration to increase gluconeogenesis or ketone production in our subjects on day 5 emphasizes the changes in hepatic metabolism which occurred after overfeeding (Fig. 2, Table IV) .
Although our data demonstrate a qualitative fall in gluconeogenesis, we are not able to quantify the extent of the decrease in rates of gluconeogenesis with overfeeding because of isotopic dilution. Dilution occurs by exchange of '4C and '2C within the TCA cycle (39) , and studies attempting to measure isotopic dilution after overfeeding are not available in the literature. However, the fall in urinary nitrogen excretion (0.007±0.001 to 0.003+0.001 gm/min) after overfeeding is consistent with a decrease in gluconeogenesis (25) . Thus, it seems likely that gluconeogenesis was suppressed and glycogenolysis increased by overfeeding. The increase in HGO observed in the present studies suggests that the production of G-6-P from glycogen provided increased substrate for G-6-Pase.
G-6-Pase catalyzes the final step in hepatic (and renal) glucose production from G-6-P derived from either gluconeogenesis or glycogenolysis. Enzyme activity is known to increase in insulin-deficient states and falls with insulin administration in streptozotocin animals (40) . Whether mild hyperinsulinemia such as that produced by overfeeding suppresses G-6-Pase activity in non-diabetic man is not known. Rossetti and colleagues have recently shown that acute hyperinsulinemia leads to a modest 20-30% suppression of maximal G-6-Pase activity without altering Km in diabetic and non-diabetic rats (41) . Moreover, we have shown that chronic hyperinsulinemia suppresses G-6-Pase activity and G-6-Pase mRNA in rats (unpublished observations). However, even if Vm. for G-6-Pase was suppressed by hyperinsulinemia in the present studies, a sufficient increase in substrate delivery might be expected to increase G-6-P phosphohydrolysis and HGO.
HGO is also increased in NLDDM. Recent studies have demonstrated that the increase in HGO is observed only when fasting plasma glucose levels exceed 7.8 mM, a level frequently used to define the diabetic state, but is not easily observed in patients with mild diabetes (42) . Nevertheless, rates of glucose release by the liver are clearly inappropriate for the level of plasma glucose in all subjects with NIDDM. Although the activity or enzyme mass of G-6-Pase is not established in NIDDM, increased substrate for the enzyme, derived from either gluconeogenesis or glycogenolysis or both, must be present to explain an increase in HGO. The present studies suggest that an increase in glycogenolysis is sufficient to overwhelm hepatic autoregulatory mechanisms and increase HGO in nondiabetic subjects. In patients with NIDDM, increased gluconeogenesis is thought to be responsible for the increase in HGO (5, 6) . However, an increase in gluconeogenesis and FFA oxidation does not increase HGO in nondiabetic man (8) , suggesting that either impaired glycogen storage or impaired suppression of glycogenolysis must contribute to the impairment of hepatic autoregulation in NIDDM.
In conclusion, we have demonstrated an increase in HGO after 5 d of carbohydrate overfeeding in nondiabetic men and women despite an increase in insulin secretion and glucose cycle activity. The suppression of gluconeogenesis observed in these studies suggests that the increase in HGO is derived from enhanced release of liver glycogen. By analogy, we suggest a contributory role of the well-preserved hepatic glycogen stores to the increased HGO in diabetic man.
